Compounds > trifluridine
Page last updated: 2024-08-17

trifluridine and Appendiceal Neoplasms

trifluridine has been researched along with Appendiceal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinoshita, H; Miki, A; Nakamura, D; Sugiyama, T; Tsubono, M; Uchida, S1
Aria, AB; Chen, L; Chon, SY; Glass, WF; Lahoti, A1

Other Studies

2 other study(ies) available for trifluridine and Appendiceal Neoplasms

ArticleYear
[Two Cases of Long-Term Use of TAS-102 for Unresectable Colorectal Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:8

    Topics: Aged, 80 and over; Appendiceal Neoplasms; Drug Combinations; Female; Humans; Male; Pyrrolidines; Rectal Neoplasms; Recurrence; Thymine; Treatment Outcome; Trifluridine; Uracil

2018
Leukocytoclastic vasculitis with late-onset Henoch-Schönlein purpura after trifluridine/tipiracil treatment.
    Dermatology online journal, 2018, Oct-15, Volume: 24, Issue:10

    Topics: Adult; Appendiceal Neoplasms; Fatal Outcome; Glomerulonephritis; Humans; IgA Vasculitis; Kidney Failure, Chronic; Male; Neoplasm Metastasis; Pyrrolidines; Thymine; Trifluridine; Vasculitis, Leukocytoclastic, Cutaneous

2018